News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Daily News Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI L.A. McKeown October 09, 2025
News Daily News EuroPCR 2025 Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE Michael O'Riordan May 28, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
Presentation TCT 2024 One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial Presenter: Michael Reardon October 30, 2024
Presentation TCT 2024 Benefits of MR Elimination & "Why TMVR" Presenter: Michael Reardon October 29, 2024
Presentation NY Valves 2024 Global Experience With Transapical TMVR - Does Access Impact Clinical Outcomes? Presenter: Michael J. Reardon June 07, 2024
Presentation NY Valves 2024 Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy Presenter: Michael J. Reardon June 07, 2024
Presentation NY Valves 2024 TAVR Will Have a Longer Lasting Durability Than SAVR Presenter: Michael J. Reardon June 06, 2024
Presentation NY Valves 2024 Hemodynamic Performance and Restoration of Laminar Flow Presenter: Michael J. Reardon June 05, 2024
Presentation NY Valves 2024 The Lifetime Management of Aortic Stenosis: A Heart Team Perspective Presenter: Michael J. Reardon June 05, 2024
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
Presentation TCT 2023 Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR) Presenter: Michael Reardon October 25, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
Presentation TCT 2023 Four-Year Outcomes From the EVOLUT Low Risk Trial Presenter: Michael Reardon October 24, 2023
Presentation TCT 2023 China Experiences with J-Valve TAVR for Both Aortic Regurgitation and Stenosis Presenter: Michael Reardon October 23, 2023